CSPC Pharma (01093) announced interim results: 2026年中期業績, net profit attributable to owners RMB60.9bn Title: 2026年中期業績 Revenue: RMB185.9bn Net profit: RMB64.6bn Profit attributable to owners: RMB60.9bn
